Related Experiment Videos

Vesico-ureteric reflux: occurrence and long-term risks

S H Jacobson1, S Hansson, B Jakobsson

  • 1Department of Nephrology, Karolinska Hospital, Stockholm, Sweden.

Insights

Vesico-ureteric reflux (VUR) is more common in specific groups and can lead to kidney scarring, hypertension, and renal failure. Early detection and treatment in children can improve long-term outcomes.

Area of Science:

  • Pediatric Nephrology
  • Urology
  • Internal Medicine

Background:

  • Vesico-ureteric reflux (VUR) prevalence in the general population is unknown.
  • VUR is elevated in specific risk groups, including children with urinary tract infections (UTIs), asymptomatic bacteriuria in schoolgirls, first-degree relatives of VUR patients, and children with prenatal upper urinary tract dilatation.
  • Pyelonephritic renal scarring in children and adults poses risks for severe long-term complications like hypertension and renal failure.

Purpose of the Study:

  • To highlight the significance of early detection and treatment of UTIs and VUR in pediatric populations.
  • To discuss the long-term complications associated with pyelonephritic renal scarring.
  • To explore management strategies for adult patients with established renal scarring.

Main Methods:

  • Review of existing literature on vesico-ureteric reflux and pyelonephritis.
  • Analysis of risk factors associated with VUR.
  • Discussion of current and potential treatment modalities for VUR and its sequelae.

Main Results:

  • VUR is more prevalent in identified pediatric risk groups.
  • Pyelonephritic renal scarring is linked to serious long-term health issues, including hypertension and renal failure.
  • Early intervention in childhood and adolescence may enhance long-term prognosis.

Conclusions:

  • Prompt diagnosis and management of UTIs and VUR in children are crucial for improving long-term renal health.
  • In adults with established pyelonephritic renal scarring, hypertension management is vital.
  • Angiotensin-converting enzyme inhibitors may offer renal protection in adult patients with established scarring.

Related Concept Videos